Outcomes of Anti-HIV Therapy During Early HIV Infection

Completed

Conditions studied: HIV Infections

In brief

The purpose of this study is to find out if it is effective to give aggressive anti-HIV therapy to patients who have been infected recently with HIV. Many doctors recommend that patients who have recently been infected with HIV begin anti-HIV treatment as soon as possible. However, early HIV infection is not yet completely understood, so it is not known if this is the best approach. This study will look at the effects of beginning anti-HIV treatment during early HIV infection.

Key facts

Study ID

NCT00001093

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

48

Starts

1999-10-01

Expected to finish

2007-06-01

Last updated by the study team

2012-10-29

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are at least 13 years old.
• Have acute or early HIV infection. The stage of HIV infection will depend on the results from certain lab tests.

You may not qualify if…

• Patients will not be eligible for this study if they:
• Are pregnant or breast-feeding.

Where it is running

• Cedars Sinai Med Ctr — Los Angeles, California, United States
• UCSD — San Diego, California, United States
• San Francisco Gen Hosp / UCSF AIDS Program — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.